Mannitol administration should stop if significant electrolyte abnormalities develop or the osmolality reaches 320 mOsm or higher. When mannitol is used to treat cerebral edema, serum osmolality should be checked every 4 to 6 hours.
How long can mannitol be given?
Conclusions: Mannitol use every 4 hours per day has evident effect of reducing the intracranial pressure in the 1st, 2nd, 3rd, and 4th day, then mannitol should be used temporarily according to the intracranial pressure after the 5th day. Mannitol should not be used for more than 8 days.
What happens after mannitol administration?
Adverse reactions more commonly reported during or after the infusion of mannitol (mannitol (mannitol injection) injection) include: Pulmonary congestion, fluid and electrolyte imbalance, acidosis, electrolyte loss, dryness of mouth, thirst, marked diuresis, urinary retention, edema, headache, blurred vision.
Why is mannitol used for cerebral edema?
Mannitol is the most popular osmotic agent. Osmotic therapy using mannitol reduces ICP by mechanisms that remain unclear. Mannitol is thought to decrease brain volume by decreasing overall water content, to reduce blood volume by vasoconstriction, to reduce CSF volume by decreasing water content.
Is mannitol used for hypertension?
Mannitol is the most commonly used hyperosmotic agent in neurosurgery. Being an agent that increases intravascular volume by withdrawing water from the brain, it may cause significant changes in stroke volume (SV), cardiac output (CO), systemic vascular resistance and blood pressure.
How much mannitol do you give?
The general dose range is 50 to 200 g mannitol (500 ml to 2000 ml/day) in a 24 hour period, with a dosage limit of 50 g (500ml mannitol) on any one occasion. In most instances, adequate response will be achieved at a dosage of 50 to 100 g mannitol/day (500 ml to 1000 ml /day).
Does mannitol lower BP?
There was a mild decrease in blood pressure and a mild increase in cerebral blood flow following mannitol, but little difference between the first hour following a bolus (when the viscosity and hematocrit were decreased) and hours 2-4 (when they were near baseline).
What is a normal brain pressure?
Intracranial pressure (ICP) is the pressure exerted by fluids such as cerebrospinal fluid (CSF) inside the skull and on the brain tissue. ICP is measured in millimeters of mercury (mmHg) and at rest, is normally 7–15 mmHg for a supine adult.
Does mannitol decrease heart rate?
Heart rate values from 25 to 45 minutes were significantly lower compared with the premannitol values (P<0.05). All the postmannitol systolic blood pressure values were significantly lower than the premannitol value (P<0.05). SV increased significantly for 15 minutes after administration of mannitol (P<0.05).
Why mannitol is given in head injury?
Background. Mannitol is sometimes effective in reversing acute brain swelling, but its effectiveness in the ongoing management of severe head injury remains unclear. There is evidence that, in prolonged dosage, mannitol may pass from the blood into the brain, where it might cause increased intracranial pressure.
How does mannitol help reduce ICP?
Mannitol exerts its ICP-lowering effects via two mechanisms—an immediate effect because of plasma expansion and a slightly delayed effect related to its osmotic action. The early plasma expansion reduces blood viscosity and this in turn improves regional cerebral microvascular flow and oxygenation.
Does mannitol drop BP?
What is mannitol used to treat?
Mannitol, given as a hypertonic solution, is primarily used in the treatment of cerebral edema and glaucoma.
What are the precautions for the administration of mannitol?
Precautions. Neurosurgical patients receiving intravenous mannitol should be monitored for increased cerebral blood flow. Mannitol should not be administered until renal function and urinary output are determined to be adequate. Cardiovascular status should be established prior to rapid administration of mannitol.
How long does it take for mannitol to leave your system?
Mannitol Injection – Clinical Pharmacology. When administered intravenously mannitol is confined to the extracellular space, only slightly metabolized and rapidly excreted by the kidney. Approximately 80% of a 100 g dose appears in the urine in 3 hours.
How is mannitol administered in the treatment of renal impairment?
A test dose should be administered in patients with severe renal impairment. Diuresis caused by mannitol administration may exacerbate electrolyte imbalances. Electrolytes should be closely monitored, especially sodium and potassium, during mannitol administration. Urine output should be monitored during mannitol infusion.
